Skip to 0 minutes and 22 seconds DR.
Skip to 0 minutes and 22 seconds PATRICIA LALOR: Hello, I’m Doctor Patricia Lalor, and I’m a senior lecturer at the Centre for Liver Research at the University of Birmingham.
Skip to 0 minutes and 29 seconds PROFESSOR PHIL NEWSOME: My name is Professor Phil Newsome, and I am director for the Centre for Liver Research and a consultant hepatologist at the Queen Elizabeth Hospital in Birmingham. DR.
Skip to 0 minutes and 39 seconds ZANIA STAMATAKI: My name is Dr. Zania Stamataki, and I am a Royal Society Research Fellow based in the Centre for Liver Research at the University of Birmingham. DR.
Skip to 0 minutes and 48 seconds PATRICIA LALOR: Liver disease is a growing global problem, and many of you may know someone who has died from end-stage liver failure or liver cancer. Here in the UK, deaths from liver disease have increased dramatically in recent years. And it seems that we are following the trend seen in America where fatty liver conditions are the leading cause of chronic liver disease. Liver disease often doesn’t present with any outward signs or symptoms until the damage is severe, at which point, the only treatment option may be having another transplant.
Skip to 1 minute and 19 seconds PROFESSOR PHIL NEWSOME: Here in Birmingham, we have one of the largest liver transplant centres in Europe and perform around 200 liver transplants per year. We also have a centre of excellence in the study of the science behind liver disease here at the University of Birmingham. We are, therefore, uniquely placed to try and teach you about the science behind liver transplantation. We will talk to the surgeons who perform the operations, the clinical staff who care for the patients, as well as the transplant coordinators who play a key role in helping source and allocate the donor organs. Finally, we’ll also hear from the patients themselves and hear about their experiences with the transplant procedure. DR.
Skip to 1 minute and 59 seconds ZANIA STAMATAKI: When first conceived, the concept of liver transplantation struggled to convince liver doctors that it was going to catch on. Nowadays, liver transplantation is the only lifesaving treatment option for patients with end-stage liver disease. During this free course, we will explore the major issues that fascinate us. How is it possible to take an organ like the liver for one person and have it survive inside another? Have you ever wondered about the ethics of organ donation and how organs should be allocated? Did you know you can use a liver from one person to supply donor material for two recipients? And why is there such an increasing demand for donor livers for transplantation?
Skip to 2 minutes and 43 seconds And how can new advances increase the number of organs which are available? DR.
Skip to 2 minutes and 47 seconds PATRICIA LALOR: If you have an interest in liver disease, or transplantation surgery, or if you’re interested in the biology behind organ transplantation and your immune system, sign up for our free course.
